These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3425457)

  • 1. Respiratory syncytial virus-specific IgE antibody responses at the mucosal surface: predictive value for recurrent wheezing and suppression by ribavirin therapy.
    Welliver RC; Ogra PL
    Adv Exp Med Biol; 1987; 216B():1701-8. PubMed ID: 3425457
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis.
    Welliver RC; Sun M; Rinaldo D; Ogra PL
    J Pediatr; 1986 Nov; 109(5):776-80. PubMed ID: 3772657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection.
    Rosner IK; Welliver RC; Edelson PJ; Geraci-Ciardullo K; Sun M
    J Infect Dis; 1987 May; 155(5):1043-7. PubMed ID: 3559277
    [No Abstract]   [Full Text] [Related]  

  • 4. Early ribavirin aerosol treatment of respiratory syncytial virus infection in high-risk children.
    Lauer B
    Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S83. PubMed ID: 2235211
    [No Abstract]   [Full Text] [Related]  

  • 5. The respiratory syncitial virus and its role in acute bronchiolitis.
    Everard ML; Milner AD
    Eur J Pediatr; 1992 Sep; 151(9):638-51. PubMed ID: 1396923
    [No Abstract]   [Full Text] [Related]  

  • 6. Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus.
    Bui RH; Molinaro GA; Kettering JD; Heiner DC; Imagawa DT; St Geme JW
    J Pediatr; 1987 Jan; 110(1):87-90. PubMed ID: 3794891
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.
    McIntosh K; Fishaut JM
    Prog Med Virol; 1980; 26():94-118. PubMed ID: 6999535
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodynamic alterations in patients treated with ribavirin.
    Eisenberg J
    Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S93-4. PubMed ID: 2235215
    [No Abstract]   [Full Text] [Related]  

  • 9. Defective regulation of immune responses in respiratory syncytial virus infection.
    Welliver RC; Kaul TN; Sun M; Ogra PL
    J Immunol; 1984 Oct; 133(4):1925-30. PubMed ID: 6236259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New data on clinical efficacy of ribavirin.
    Stutman HR; Rub B; Janaim HK
    Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S79-82. PubMed ID: 2235210
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections.
    Nadal D; Ogra PL
    Lung; 1990; 168 Suppl():379-87. PubMed ID: 2117140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants.
    Taber LH; Knight V; Gilbert BE; McClung HW; Wilson SZ; Norton HJ; Thurson JM; Gordon WH; Atmar RL; Schlaudt WR
    Pediatrics; 1983 Nov; 72(5):613-8. PubMed ID: 6356005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchodilator response during acute viral bronchiolitis in infancy.
    Soto ME; Sly PD; Uren E; Taussig LM; Landau LI
    Pediatr Pulmonol; 1985; 1(2):85-90. PubMed ID: 4069797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus and ribavirin.
    Sullivan BJ
    Pediatr Infect Dis; 1986; 5(5):605-6. PubMed ID: 3763427
    [No Abstract]   [Full Text] [Related]  

  • 15. Ribavirin therapy for acute bronchiolitis: need for appropriate controls.
    Moler FW; Bandy KP; Custer JR
    J Pediatr; 1991 Sep; 119(3):509-10. PubMed ID: 1880677
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bronchiolitis caused by respiratory syncytial virus in very young infants and transmitted maternal antibodies].
    Attree O; Tourangeau F; De Saint-Maur G; Alvarez-Vega M; Nicolas JC; Garbarg-Chenon A; Bricout F
    Arch Fr Pediatr; 1988 Dec; 45(10):791-3. PubMed ID: 3071286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years.
    Welliver RC; Duffy L
    Pediatr Pulmonol; 1993 Jan; 15(1):19-27. PubMed ID: 8419894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological studies of the relation between respiratory syncytial virus (RSV) and bronchiolitis].
    Nigro N; Togliatto G
    Minerva Pediatr; 1981 Jan; 33(1):47-8. PubMed ID: 7242476
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of IgE in pathogenesis of mucosal viral infections.
    Welliver RC; Ogra PL
    Ann N Y Acad Sci; 1983 Jun; 409():321-32. PubMed ID: 6191613
    [No Abstract]   [Full Text] [Related]  

  • 20. Respiratory syncytial virus and the infant immune response.
    Toms GL; Scott R
    Arch Dis Child; 1987 Jun; 62(6):544-6. PubMed ID: 3619469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.